Drug Profile
Lenercept
Alternative Names: p55TNFR-Ig; RO 452081; Tenefuse; TNFr IgG1; TNFR55 IgG1Latest Information Update: 08 Apr 2004
Price :
$50
*
At a glance
- Originator Roche
- Developer Genentech; Roche
- Class Anti-inflammatories; Antirheumatics; Recombinant fusion proteins
- Mechanism of Action Immunosuppressants; Tumour necrosis factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic asthma; Rheumatoid arthritis; Septic shock